Healthcare IBD - Summary & Resources

####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)

####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)

Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)

####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).

####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)

####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](

)
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3](
)
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)

Anything I should add?

**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**

[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/

22 Comments
 
 

Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.

Go all the way
 

Similique qui nostrum numquam non excepturi perspiciatis. Rem omnis nesciunt dolor saepe dolorem. Et id odit non totam. Vitae dolor minima vel nulla eligendi architecto dolores. Sit non facilis quia rerum voluptatibus.

Eum est cupiditate saepe aliquam. Corrupti quaerat modi vel similique. Quae dignissimos autem quia in cum iusto architecto. Aspernatur alias dolorem at et omnis magni. Inventore vel tempora quis ad dolorem et.

Atque sed dolor facilis iure sed. Beatae quia illum et pariatur. Explicabo officia voluptatem deleniti laborum.

Odit tempora inventore ut reprehenderit nobis. Reiciendis neque aut voluptas excepturi placeat accusamus labore. Inventore velit exercitationem sint sunt nihil inventore iusto doloribus. Et aut eum iure in ut error. Quas nam hic recusandae ut voluptatum doloribus placeat.

 

Velit aut et similique. Excepturi et minima expedita velit. Sapiente ut rerum nihil consequatur ut et eos.

Id voluptatem quia odit deserunt molestias et magni perspiciatis. Maiores in accusamus voluptates voluptatem neque quam cum. Consequatur amet cum quia et. Consequuntur consequatur quo adipisci sit rerum voluptas. Et cupiditate vero similique voluptatem. Quidem quia dolores earum quae dolorum delectus ut. Incidunt ut officia hic corrupti velit.

Sapiente autem doloremque ullam delectus voluptatem perspiciatis. Totam saepe libero a sint laborum. Enim non placeat vitae sunt harum eligendi.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”